awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q40485092-C69292A6-EADC-45E3-85FE-13BC5C6BCBFC
Q40485092-C69292A6-EADC-45E3-85FE-13BC5C6BCBFC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40485092-C69292A6-EADC-45E3-85FE-13BC5C6BCBFC
Safety, efficacy, and pharmacokinetics of navitoclax (ABT-263) in combination with erlotinib in patients with advanced solid tumors.
P2860
Q40485092-C69292A6-EADC-45E3-85FE-13BC5C6BCBFC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40485092-C69292A6-EADC-45E3-85FE-13BC5C6BCBFC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6b7b096aeab63dc4f8b8daec09e97d8ba8bdea26
P2860
Erlotinib at a dose of 25 mg daily for non-small cell lung cancers with EGFR mutations.